Related Experiment Videos
Pharmacological approaches to migraine
1Department of Neurology, University Essen, Federal Republic of Germany. h.diener@uni-essen.de
Journal of Neural Transmission. Supplementum
|July 2, 2003
Summary
This review explores new migraine treatments, highlighting the effectiveness of triptans for acute attacks and various medications for prophylaxis. It aids in selecting optimal migraine therapies based on individual needs.
Area of Science:
- Neurology
- Pharmacology
Background:
- Migraine is a debilitating neurological disorder characterized by severe headaches and associated symptoms.
- Current treatments include analgesics, NSAIDs, ergotamines, and triptans for acute attacks.
Purpose of the Study:
- To review and summarize novel therapeutic options for both acute migraine attacks and long-term migraine prophylaxis.
- To compare the efficacy and side effect profiles of various treatment modalities.
Main Methods:
- Literature review of controlled trials and clinical studies on migraine treatments.
- Analysis of pharmacological profiles and clinical efficacy data for different drug classes.
Main Results:
- Triptans (serotonin 5-HT1B/D agonists) demonstrate high efficacy in treating acute migraine attacks, improving headache and associated symptoms.
- Established prophylactic agents include beta-blockers, calcium channel blockers, and amitriptyline.
- Newer prophylactic options like antiepileptic drugs (valproic acid, gabapentin, topiramate) are under investigation.
Conclusions:
- Triptans offer effective acute migraine treatment with minor variations in efficacy and side effects.
- Migraine prophylaxis is recommended for frequent or severe attacks, with multiple medication classes available.
- Individualized treatment selection based on pharmacological profiles and patient characteristics is crucial for optimal migraine management.